Capital World Investors Novo Cure LTD Put Options Transaction History
Capital World Investors
- $659 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
284Shares Held
77.5MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$147 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$131 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$83.9 Million9.53% of portfolio
-
State Street Corp Boston, MA2.68MShares$32.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.44MShares$29.7 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.28B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...